Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Online Family Support and Education for Schizophrenia
This study is ongoing, but not recruiting participants.
Sponsored by: National Institute of Mental Health (NIMH)
Information provided by: National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier: NCT00046085
  Purpose

This study will evaluate the benefits of providing families of schizophrenia patients the opportunity to interact with each other using the Internet.


Condition Intervention
Schizophrenia
Behavioral: Family Psychoeducational Program

MedlinePlus related topics: Schizophrenia
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Online Family Support and Education for Schizophrenia

Further study details as provided by National Institute of Mental Health (NIMH):

Estimated Enrollment: 72
Study Start Date: March 2001
Detailed Description:

Although psychoeducational programs for schizophrenia can reduce patient relapse rates and reduce family distress, participation rates are often low. This study will provide the families of schizophrenia patients with knowledge of illness management to reduce family burden and increase perceived social support.

Relatives of patients with schizophrenia receive either 18 months of customary care or 18 months of customary care with access to the educational website for the first year. Families are provided with private, secure access to the website, which features family-to-family chat capabilities, video lectures on the management of schizophrenia, written materials on important issues in schizophrenia management, professionally facilitated online discussions of the material, and additional resource links.

Relatives have 90-minute interviews at the beginning of the project and every 6 months for 18 months. The interviews are used to assess the family member's perception of the patient's symptoms, his or her knowledge of the illness, the illness's impact on the family member, and his or her perception of the website intervention.

Patients with schizophrenia or schizoaffective disorder are also asked to complete interviews and assessments at the beginning of the project and every 3 months for 18 months. The assessments include questions about symptoms, medication compliance and side effects, hospitalizations, and social functioning.

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria for Patients:

  • DSM-IV diagnosis of schizophrenia or schizoaffective disorder
  • Stable antipsychotic medication regimen for at least 1 month
  • Able to come to the West Los Angeles area for assessments

Inclusion Criteria for Relatives:

  • At least 4 hours of weekly contact with patient
  • Access to a computer and Internet connection; expect to stay online for the next 12 months
  • Able to come to the West Los Angeles area for assessments
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00046085

Locations
United States, California
VA Greater Los Angeles Healthcare System
Los Angeles, California, United States, 90073
Sponsors and Collaborators
  More Information

Study ID Numbers: R21 MH62135, DSIR AT-SP
Study First Received: September 19, 2002
Last Updated: December 1, 2005
ClinicalTrials.gov Identifier: NCT00046085  
Health Authority: United States: Federal Government

Keywords provided by National Institute of Mental Health (NIMH):
Schizoaffective disorder
Diagnosis, Dual (Psychiatry)
Psychoeducation
Internet

Study placed in the following topic categories:
Schizophrenia
Mental Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on January 15, 2009